Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience

Fulltext

Tan EK ¹ , Albanese A ² , Chaudhuri K ³ , Lim SY ⁴ , Oey NE ⁵ , Shan Chan CH ⁶ Show all authors , Wu YC ⁷ , Jeon B ⁸ , Truong D ⁹ , Poewe W ¹⁰ , Pal PK ¹¹ , Tan L ¹² , Opal P ¹³ , Colosimo C ¹⁴ , Jinnah HA ¹⁵ , Cardoso F ¹⁶

¹ National Neuroscience Institute, Singapore. Electronic address: [email protected]
² IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy. Electronic address: [email protected]
³ Kings College and Kings College Hospital, London, United Kingdom. Electronic address: [email protected]
⁴ University of Malaya, Kuala Lumpur, Malaysia. Electronic address: [email protected]
⁵ National Neuroscience Institute, Singapore. Electronic address: [email protected]
⁶ National Neuroscience Institute, Singapore. Electronic address: [email protected]
⁷ Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China. Electronic address: [email protected]
⁸ Seoul National University Hospital, Seoul, South Korea. Electronic address: [email protected]
⁹ University of California, USA. Electronic address: [email protected]
¹⁰ Medical University of Innsbruck, Austria. Electronic address: [email protected]
¹¹ National Neuroscience Institute of Mental Health and Neurosciences, Bangalore, India. Electronic address: [email protected]
¹² National Neuroscience Institute, Singapore. Electronic address: [email protected]
¹³ Northwestern University, USA. Electronic address: [email protected]
¹⁴ Azienda Ospedaliera Santa Maria, Terni, Italy. Electronic address: [email protected]
¹⁵ Emory University School of Medicine, USA. Electronic address: [email protected]
¹⁶ Federal University of Minas Gerais, Belo Horizonte MG, Brazil. Electronic address: [email protected]

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.